Dermapharm AG secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient adapalene benzoyl peroxide, ATC D10AD23 for the period 01022024 - 31012026

Germany, Jan. 29 -- Germany based Dermapharm AG has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient adapalene benzoyl peroxide, ATC D10AD23 for the period 01022024 - 31012026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....